14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AVGO vs MCHPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Broadcom Inc. (AVGO) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AVGO carries a Unified Composite Score of 53.7/100 (HOLD) at $333.76 (17.8x Forward P/E, 48.8% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).
Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AVGO 53.7/100 HOLD), AVGO captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (48.8% vs. 21.6% operating margin) and revenue trajectory (+85.5% vs. +42.2% YoY).
Technical & Structure Timing Caution: AVGO is currently in a Breakdown options structure phase (RSI 48.6); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVGO vs MCHPP. Trailing 12-month operating profitability (AVGO 48.8% vs MCHPP 21.6%) and valuation multiples (AVGO 17.8x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ AVGO vs MCHPP Key Questions & Quantitative Answers
As of Nov 16, 2026, Broadcom Inc. (AVGO) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AVGO carries a Unified Composite Score of 53.7/100 (HOLD) at $333.76 (17.8x Forward P/E, 48.8% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AVGO 53.7/100 HOLD), AVGO captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (48.8% vs. 21.6% operating margin) and revenue trajectory (+85.5% vs. +42.2% YoY). Technical & Structure Timing Caution: AVGO is currently in a Breakdown options structure phase (RSI 48.6); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AVGO leads the Growth & Scale pillar: AVGO posts +85.5% YoY revenue growth and +215.3% YoY earnings growth on $89.1B TTM revenue (75.5% gross margin, 48.8% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, AVGO generates $89.1B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, AVGO deploys 26.7% of Rev ($23.8B) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.
AVGO screens cheaper on headline valuation multiples. AVGO trades at 17.8x Forward P/E, 46.5x Trailing P/E, 0.34x PEG, and 19.9x EV/Revenue (44.2% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AVGO (44.2% ROE) versus MCHPP (12.6% ROE) capital efficiency.
In options market volatility and institutional positioning, AVGO carries 29.3% implied volatility (24th %ile, Compressed (<25th %ile)), a 1.10x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.17β · 70% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.